Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a price target of $26.00. Larry Biegelsen has given his Buy ...

Cathleen McCabe, MD has joined Bausch + Lomb as strategic medical advisor. Palvella Therapeutics named Matthew E. Korenberg as CFO. Disc Medicine appointed Rahul Kaushik as CTO. Inspire, an online ...

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout of Bausch + Lomb, according to people with knowledge of the matter. A ...

“I’m optimistic,” Bausch + Lomb CEO Brent Saunders told STAT. Zach Weinberg, CEO of Curie.Bio, said that while Trump’s policies on health care have been known to shift, “R.F.K. is scary ...

The company reports revenues under five segments — Salix, International, Diversified Products, Solta Medical and Bausch + Lomb. Salix revenues totaled $642 million, up 5% year over year.

Bausch + Lomb has bought US and Canadian rights to a potential biosimilar competitor to Novartis’ Lucentis from Germany’s Stada, as the blockbuster approaches the end of its patent ...

AMD is a leading global semiconductor company with a business portfolio spanning client products, servers, embedded systems, and AI accelerators. Reporting 2023 revenues of $23.6 billion, AMD has ...

https://www.tipranks.com/news/company-announcements/cencora-reports-strong-revenue-and-eps-growth-in-2024 Bullish option flow detected in Bausch Health (BHC) with ...

to $10 from $8.50 and keeps a Sector Perform rating on the shares ahead of the company’s Q3 report due after market close on October 30 following Bausch + Lomb’s (BLCO) Q3 results due before ...

Right now, the recently released AMD Ryzen 7 9800X3D AM5 desktop processor is back in stock at Amazon at its retail price of $479 shipped. This is the official launch price with zero markup ...